Sign Out
Acute or recurrent vaginal candidiasis.
Mucosal candidiasis, including oropharyngeal, oesophageal, non invasive bronchopulmonary infection, candiduria, mucocutaneous and chronic oral atrophic candidiasis.
Tinea pedis, tinea cruris, tinea corporis, tinea versicolor and dermal Candida infection.
Systemic candidiasis, such as candidaemia, disseminated candidiasis and invasive candidal infection of the peritoneum, endocardium and urinary and pulmonary tracts.
Cryptococcosis, including pulmonary and cutaneous infections and cryptococcal meningitis. In AIDS patients, as a maintenance therapy to prevent relapse of cryptococcal disease.
Prevention of fungal infection in immunocompromised patients at risk as a result of neutropenia following cytotoxic chemotherapy or radiotherapy.
